Vedolizumab Maintenance Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01522 ◽

2012 ◽

Vol 107 ◽

pp. S609-S610 ◽

Cited By ~ 2

Author(s):

Brian Feagan ◽

Paul Rutgeerts ◽

Bruce Sands ◽

William Sandborn ◽

Jean-Frederic Colombel ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Phase 3 ◽

Double Blind ◽

Multicenter Phase

Download Full-text

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-Maintenance

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01665 ◽

2012 ◽

Vol 107 ◽

pp. S673-S674

Author(s):

William Sandborn ◽

Brian Feagan ◽

Colleen Marano ◽

Richard Strauss ◽

Jewel Johanns ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Blind Study ◽

Double Blind Study ◽

Active Ulcerative Colitis ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy

Download Full-text

Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study)

Journal of Gastroenterology ◽

10.1007/s00535-017-1326-1 ◽

2017 ◽

Vol 52 (10) ◽

pp. 1101-1111 ◽

Cited By ~ 20

Author(s):

Toshifumi Hibi ◽

Yuya Imai ◽

Asako Senoo ◽

Kentaro Ohta ◽

Yoshifumi Ukyo

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Japanese Patients ◽

Controlled Study ◽

Active Ulcerative Colitis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind

Download Full-text

943b Induction Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial

Gastroenterology ◽

10.1016/s0016-5085(12)60607-6 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-160-S-161 ◽

Cited By ~ 24

Author(s):

B.G. Feagan ◽

P.J. Rutgeerts ◽

B.E. Sands ◽

J. Colombel ◽

W.J. Sandborn ◽

...

Keyword(s):

Ulcerative Colitis ◽

Induction Therapy ◽

Phase 3 ◽

Double Blind ◽

Multicenter Phase

Download Full-text

Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00295-8 ◽

2021 ◽

Cited By ~ 2

Author(s):

Severine Vermeire ◽

Peter L Lakatos ◽

Timothy Ritter ◽

Stephen Hanauer ◽

Brian Bressler ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Active Ulcerative Colitis ◽

Phase 3 ◽

Double Blind

Download Full-text

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00073-5 ◽

2021 ◽

Author(s):

Andrés Poveda ◽

Anne Floquet ◽

Jonathan A Ledermann ◽

Rebecca Asher ◽

Richard T Penson ◽

...

Keyword(s):

Ovarian Cancer ◽

Maintenance Therapy ◽

Final Analysis ◽

Phase 3 ◽

Double Blind ◽

Platinum Sensitive

Download Full-text

321 A RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, PLACEBO AND NAPROXEN CONTROLLED, MULTICENTER PHASE 3 STUDY OF NAPROXCINOD IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE: EFFICACY RESULTS FOLLOWING 13-WEEK TREATMENT

Osteoarthritis and Cartilage ◽

10.1016/s1063-4584(09)60343-5 ◽

2009 ◽

Vol 17 ◽

pp. S171-S172

Author(s):

C.E. Marrero ◽

C. Tuten ◽

T. Shamim ◽

V. Awasty ◽

J. Agaiby ◽

...

Keyword(s):

Osteoarthritis Of The Knee ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Multicenter Phase ◽

Parallel Group

Download Full-text

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00298-3 ◽

2021 ◽

Author(s):

Laurent Peyrin-Biroulet ◽

Ailsa Hart ◽

Peter Bossuyt ◽

Millie Long ◽

Matthieu Allez ◽

...

Keyword(s):

Ulcerative Colitis ◽

Randomised Controlled Trial ◽

Maintenance Therapy ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Controlled Trial ◽

Phase 3 ◽

Previously Treated ◽

Randomised Controlled ◽

Necrosis Factor

Download Full-text

PD-008 Adding ramucirumab to second-line irinotecan, 5-fluorouracil and folinic acid (FOLFIRI) treatment for metastatic colorectal carcinoma (mCRC): resource utilization data from RAISE, a global, randomized, double-blind, multicenter phase 3 study

Annals of Oncology ◽

10.1093/annonc/mdw200.08 ◽

2016 ◽

Vol 27 ◽

pp. ii104

Author(s):

J. Kisro ◽

A. Cohn ◽

T. Yoshino ◽

E. Van Cutsem ◽

S. Hegewisch-Becker ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Folinic Acid ◽

Resource Utilization ◽

Second Line ◽

Metastatic Colorectal Carcinoma ◽

Phase 3 ◽

Double Blind ◽

Multicenter Phase ◽

Utilization Data

Download Full-text

642 Effects of Ustekinumab Maintenance Therapy on Endoscopic Improvement and Histologic Improvement in the UNIFI Phase 3 Study in Ulcerative Colitis

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592104.75922.38 ◽

2019 ◽

Vol 114 (1) ◽

pp. S375-S376

Author(s):

Katherine Li ◽

Joshua R. Friedman ◽

Colleen Marano ◽

Hongyan Zhang ◽

Feifei Yang ◽

...

Keyword(s):

Ulcerative Colitis ◽

Maintenance Therapy ◽

Phase 3

Download Full-text

P148 LACK OF INFLUENCE OF ELDERLY AGE AND GENDER ON THE SAFETY PROFILE OF BUDESONIDE EXTENDED-RELEASE TABLETS FOR ULCERATIVE COLITIS: A POOLED ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PHASE 3 TRIALS

Gastroenterology ◽

10.1053/j.gastro.2017.11.197 ◽

2018 ◽

Vol 154 (1) ◽

pp. S78

Author(s):

Gary R. Lichtenstein ◽

Zeev Heimanson ◽

Brian P. Bosworth

Keyword(s):

Ulcerative Colitis ◽

Safety Profile ◽

Extended Release ◽

Pooled Analysis ◽

Elderly Age ◽

Phase 3 ◽

Double Blind ◽

Age And Gender ◽

And Gender

Download Full-text